Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Actuate Therapeutics, Inc. - Common stock (NQ:ACTU)

1.035 -0.075 (-6.76%)
Streaming Delayed Price Updated: 12:32 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 99,106
Open 1.130
Bid (Size) 1.030 (500)
Ask (Size) 1.040 (500)
Prev. Close 1.110
Today's Range 1.030 - 1.140
52wk Range 1.020 - 9.220
Shares Outstanding 23,243,328
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
Via ACCESS Newswire
News headline image
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer ↗
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026. 
Via Stocktwits

Performance

YTD
-82.8%
-82.8%
1 Month
-14.5%
-14.5%
3 Month
-65.2%
-65.2%
6 Month
-75.6%
-75.6%
1 Year
-87.1%
-87.1%

More News

Read More
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
Via Benzinga
News headline image
Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Pheton, Powell Max Make Public Debut ↗
Via Talk Markets
News headline image
Actuate Therapeutics Makes Public Debut ↗
Via Talk Markets
InvestorNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering
Via Investor Brand Network

Frequently Asked Questions

Is Actuate Therapeutics, Inc. - Common stock publicly traded?
Yes, Actuate Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Actuate Therapeutics, Inc. - Common stock trade on?
Actuate Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Actuate Therapeutics, Inc. - Common stock?
The ticker symbol for Actuate Therapeutics, Inc. - Common stock is ACTU on the Nasdaq Stock Market
What is the current price of Actuate Therapeutics, Inc. - Common stock?
The current price of Actuate Therapeutics, Inc. - Common stock is 1.035
When was Actuate Therapeutics, Inc. - Common stock last traded?
The last trade of Actuate Therapeutics, Inc. - Common stock was at 08/10/26 12:32 PM ET
What is the market capitalization of Actuate Therapeutics, Inc. - Common stock?
The market capitalization of Actuate Therapeutics, Inc. - Common stock is 24.06M
How many shares of Actuate Therapeutics, Inc. - Common stock are outstanding?
Actuate Therapeutics, Inc. - Common stock has 24M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.